Navigation Links
Dynamin drug discovery team win prestigious international epilepsy grant
Date:6/18/2008

demonstrate a clear path from the lab to the patient.

A common feature of all AEDs is a reduction in synaptic transmission. The GTPase Dynamin represents a potentially highly efficacious target that indirectly modulates neurotransmitter loading, leading to reduced epileptic synaptic transmission, while limiting potential side effects. Dynamin mediates synaptic vesicle endocytosis (SVE), a process which replenishes synaptic vesicles prior to reloading and subsequent neurotransmitter release. Modulation of Dynamin limits the efficiency of SVE to retrieve vesicles, decreasing the rate at which neurons can recycle them to sustain synaptic transmission. Hence seizure activity is minimized through depleting the sustainability of neuronal burst firing, without directly influencing the synaptic transmission process. During regular physiological conditions synaptic transmission does not rely on such rapid vesicle replenishment limiting potential mechanistic side effects.

The Dynamin Drug Discovery Program represents an extensive collaboration between Professor Phil Robinson, CMRI (Dynamin Biology), Associate Professor Adam McCluskey, University of Newcastle (Medicinal Chemistry), Associate Professor Terence O'Brien, University of Melbourne, Department of Medicine, Royal Melbourne Hospital (Translational Models) and Bio-Link Partners Ltd. (Commercialization Strategy and Implementation). The program consists of an iterative drug discovery and development cycle for development of dynamin inhibitors as novel therapeutic candidates for epilepsy, other CNS disorders and cancer. The Robinson group originally cloned the human dynamin 1 isoform, and are leaders in the understanding of its biological functions and development of in vitro and cell function assays. In conjunction with the medicinal chemistry expertise of the McCluskey group, a large number of classes of small molecule and peptide inhibitors of dynamin have been developed. Ongoing collaborations with
'/>"/>

Contact: Jens Tampe
j.tampe@bio-link.com
61-292-094-381
Research Australia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
2. New Molecule Discovery Shows Promise Against Tamoxifen-Resistant Breast Cancers
3. Stem cell discovery sheds light on placenta development
4. Discovery of new signal pathway important to diabetes research
5. Immtech Announces Results From Hepatitis C Discovery Program
6. Discovery of new family of genetic mutations involved in inflammatory intestinal disease
7. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
8. Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM)
9. Discovery of cell linked to learning and memory
10. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
11. Discovery of a novel mechanism for the development of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Specialty ... collaborating with American Eagle Outfitters on a collection ... natural beauty. , For the debut five-piece ... Aerie by American Eagle ; the retailer's ... body-image campaign, called "Aerie REAL," uses models of ...
(Date:5/5/2015)... 05, 2015 Igantia , an ... leads an international initiative to examine key biological milestones ... human lifespan. Scientists at Igantia believe that better ... the initiation of her menstrual cycle to her transition ... aging and, ultimately, extend the lifespan. , By ...
(Date:5/5/2015)... 05, 2015 Care Logistics ... called “Medicare Breakeven Challenges? A Model to ... ,     Formulas for two critical ... but should be ,     A model ... space” and ensures sustained efficient operations , ...
(Date:5/5/2015)... 05, 2015 Every year, news articles appear ... out, the worst dry eye season is spring, also known ... most of the United States. The only season offering a ... Sharon Kleyne, host of the Sharon Kleyne Hour™ Power of ... radio show of May 11, 2015. Kleyne is the inventor ...
Breaking Medicine News(10 mins):Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... Unfortunately for us, there is no formula for fulfillment or ... religion and science time and again for answers to our ... Confucius and Plato, and science continues to piece together some ... Psychologists Nansook Park and Christopher Peterson from the University ...
... at Massachusetts General Hospital (MGH) has been awarded $15 ... Diseases to investigate how the hepatitis C virus (HCV) ... The five-year grant will support a Cooperative Center for ... on how some individuals successfully recover from HCV while ...
... network of medical research institutions across the United States ... to gather critical data about influenza vaccines, including two ... the direction of the National Institute of Allergy and ... Health. "With the emergence of the 2009 ...
... ROSEMONT, Ill., July 22 The American Academy of Orthopaedic ... the treatment of pediatric diaphyseal femur fractures . ... (the bone in the thigh) is a very common childhood injury. ... treatment options for femur fracture, a thighbone injury occurring in an ...
... , WASHINGTON, July 22 ... Medical Doctors Alfred Bonati, M.D., participated yesterday in ... Committee Chairman Michael Steele. Dr. Bonati and other attendees from ... impact of health-care reform on physicians, small businesses, employees and ...
... PHILADELPHIA, July 22 New research from The Children,s ... in acting as gatekeepers for infectious viruses. By using mice genetically ... the study team prevented infection by a common virus that causes ... "This finding is a step to understanding how cell receptors ...
Cached Medicine News:Health News:Life lessons: Where psychology stands on living well 2Health News:Mass. General-based research center will investigate why immune system fails to control hepatitis C 2Health News:NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates 2Health News:NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates 3Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 2Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 3Health News:American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures 4Health News:Internationally Renowned Surgeon Reaches out to RNC, Hispanic Community 2Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 2Health News:Eliminating Cell Receptor Prevents Infections in Animal Study 3
(Date:5/5/2015)... May 5, 2015  Vaccinogen, Inc. (OTC.QB: VGEN), a ... of Directors has unanimously elected Co-founder, President, Chief Executive ... to the role of Chairman of the Board. Mr. ... who resigned from the Board and his role as ... role to pursue his candidacy for the President of ...
(Date:5/5/2015)... Bio-Techne Corporation (NASDAQ: TECH ) announced ... a dividend of $0.32 per share for the quarter ... payable May 29, 2015 to all common shareholders of ... be considered by the Board of Directors on a ... ) is a global life sciences company providing innovative ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... of the "Will Theranos Turn the Lab Industry ... Theranos has received much praise along with a healthy ... "gone public" with their potentially disruptive laboratory solution. Behind ... Has Theranos scaled microfluidic technology across a ...
Breaking Medicine Technology:Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 2Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 3Will Theranos Turn the Lab Industry Upside Down? 2
... Mass. , June 1 SynapDx Corp., a new company ... autism, announced the completion of a $9 million Series A ... Partners. , , , ... profound effect on children and their families," said Stanley N. Lapidus ...
... FRANCISCO , June 1 Prostate cancer ... FIRMAGON® (degarelix for injection) after one year of treatment ... of a Phase III extension study(1) presented here at ... used in monitoring prostate cancer patients, treatment response, and ...
Cached Medicine Technology:Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 2Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 3Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 4Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year 5
Narrow smooth jaws. Serrated handle with polished finish....
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish....
Round solid 15 mm wide lower plate. Open upper plate with inside diameter 12 mm. Serrated handle with locking thumb screw and polished finish....
Oval solid 17 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: